Tuval Ben-yehezkelMSc, PhD
Dr. Ben-Yehezkel founded Loop Genomics in 2016 as part of the Y-Combinator accelerator in order to disrupt the long-read sequencing space. Prior to Loop Genomics Dr. Ben-Yehezkel was the CEO and co-founder of Synvaccine, a viral synthetic genome engineering company and a Senior Scientist at the Weizmann Institute of Science, where he developed methods for engineering synthetic organisms. At Loop Genomics, he is directing the development and commercialization of the first hardware-free synthetic long read sequencing technology that can be used for any sequencing application. Loop’s technology transforms short-read sequencers into single-molecule long-read sequencers, offering the accuracy and resolution required for precision Microbiome, Transcriptome and DNA sequencing.